About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $18.54 (+2.71%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
DYN price activity
Last Price
$18.540
Change (24hr)
0.49 USD (2.71%)
Volume
3.65M
Volume (4w avg)
-
Open
$18.57
Day Range
$17.94 - $19.00
Previous Close
$18.05
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
DYN price performance
Delayed
04 Nov, 9:00 pm GMT+0
DYN details
DYN Market Signals